Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SAB Biotherapeutics, Inc. - Common Stock
(NQ:
SABS
)
2.540
-0.140 (-5.22%)
Delayed Quote
Updated: 12:46 PM EDT, Oct 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about SAB Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
SAB Biotherapeutics Q2 Earnings Call Highlights
↗
August 07, 2026
SAB Biotherapeutics (NASDAQ:SABS) said its registrational Phase IIb SAFEGUARD trial of SAB-142 in newly diagnosed Stage 3 Type 1 diabetes remains on track to complete enrollment in the fourth quarter...
Via
MarketBeat
Topics
Earnings
SAB Biotherapeutics Q1 Earnings Call Highlights
↗
May 12, 2026
SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the clinical-stage biopharmaceutical company reported a wider...
Via
MarketBeat
Topics
Earnings
SAB Biotherapeutics (NASDAQ:SABS) Reports Q1 2026 Miss as Clinical Progress and Extended Cash Runway Through 2028 Take Center Stage
↗
May 12, 2026
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 03, 2025
Via
Benzinga
Why Is SAB BIO Stock Trading Lower On Tuesday?
↗
January 28, 2025
SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
September 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 19, 2025
Via
Benzinga
Top movers in Friday's session
↗
September 19, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Which stocks are gapping on Friday?
↗
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Which stocks are moving before the opening bell on Wednesday?
↗
September 03, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 21, 2025
Via
Benzinga
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
↗
January 28, 2025
Via
Benzinga
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
↗
January 28, 2025
Via
Benzinga
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
↗
January 28, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 18, 2024
Via
Benzinga
SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024
↗
August 09, 2024
SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 23, 2024
Via
Benzinga
SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024
↗
May 21, 2024
SABS stock results show that SAB Biotherapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday
↗
January 03, 2024
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
↗
December 01, 2023
The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
